Detection of terminal deoxynucleotidyl transferase (TdT) in nonhematopoietic small round cell tumors of children

被引:18
作者
Mathewson, RC [1 ]
Kjeldsberg, CR [1 ]
Perkins, SL [1 ]
机构
[1] UNIV UTAH, HLTH SCI CTR, DEPT PATHOL, SALT LAKE CITY, UT 84134 USA
来源
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE | 1997年 / 17卷 / 06期
关键词
Ewing's sarcoma; immunoperoxidase; medulloblastoma; rhabdomyosarcoma; small round cell tumor; terminal deoxynucleotidyl transferase;
D O I
10.1080/107710497174291
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In the differential diagnosis of small round cell tumours (SRCTs), terminal deoxynucleotidyl transferase (TdT) is often used as a marker for lymphoblastic lymphomas and leukemias. However, the specificity of TdT using the avidin-biotin-immunoperoxidase (ABC) method is not well documented. To address this issue, we stained paraffin-embedded biopsy specimens of 64 cases of childhood SRCTs using the ABC method with anti-TdT. For any TdT-positive tumors, an additional antibody panel for lymphoid markers was applied. Two patterns of TdT positivity were observed: (1) tumor specific, consisting of strong to moderate nuclear staining, and (2) scattered positive lymphoid cells, usually in a perivascular location and expressing T-cell markers. Analysis showed that 7 of 10 medulloblastomas stained with TdT in a tumor-specific pattern (4 cases moderately to strongly positive in 75-100% of tumor cells, 3 cases weakly to moderately in 25-50% of cells). Also 1, of 19 rhabdomyosarcomas and 1 of 8 Ewing's sarcomas showed moderate to strong tumor-specific TdT staining in 100 and 10% of cells, respectively. Scattered TdT-positive lymphoid cells were observed 27% of these 64 SRCTs. These findings emphasize that TdT positivity should not be relied upon exclusively for making a diagnosis of lymphoblastic leukemia or lymphoma or ruling out other SRCTs.
引用
收藏
页码:835 / 844
页数:10
相关论文
共 44 条
[1]   TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-ACTIVITY IN NEOPLASTIC AND NONNEOPLASTIC HEMATOPOIETIC-CELLS [J].
BEARMAN, RM ;
WINBERG, CD ;
MASLOW, WC ;
RACKLIN, B ;
CARLSON, F ;
NATHWANI, BN ;
KIM, H ;
DIAMOND, LW ;
FALLIS, B ;
RAPPAPORT, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (06) :794-802
[2]  
BOLLUM FJ, 1979, BLOOD, V54, P1203
[3]   HIGH MOLECULAR-WEIGHT FORM OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE [J].
BOLLUM, FJ ;
BROWN, M .
NATURE, 1979, 278 (5700) :191-192
[4]  
BOLLUM FJ, 1982, TERMINAL TRANSFERASE, P1
[5]  
BOLLUM FJ, 1981, LEUKEMIAMARKERS, P33
[6]  
BRADSTOCK KF, 1980, J NATL CANCER I, V65, P33
[7]   TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN NON-HODGKINS LYMPHOMA [J].
BRAZIEL, RM ;
KENEKLIS, T ;
DONLON, JA ;
HSU, SM ;
COSSMAN, J ;
BOLLUM, FJ ;
JAFFE, ES .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 80 (05) :655-659
[8]   ROUTINE IMMUNOFLUORESCENT AND HISTOCHEMICAL ANALYSIS OF BONE-MARROW INVOLVEMENT OF LYMPHOMA LEUKEMIA - THE USE OF CRYOSTAT SECTIONS [J].
CHILOSI, M ;
PIZZOLO, G ;
FIOREDONATI, L ;
BOFILL, M ;
JANOSSY, G .
BRITISH JOURNAL OF CANCER, 1983, 48 (06) :763-775
[9]  
DEHNER LP, 1987, PEDIAT SURG PATHOLOG, P1006
[10]  
EBENER U, 1990, ANTICANCER RES, V10, P887